126 related articles for article (PubMed ID: 36709941)
21. Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas.
Zhan P; Shen XK; Qian Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK
Med Oncol; 2012 Jun; 29(2):648-55. PubMed ID: 21519871
[TBL] [Abstract][Full Text] [Related]
22. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
23. Circular RNA_0001946 is insufficiently expressed in tumor tissues, while its higher expression correlates with less lymph node metastasis, lower TNM stage, and improved prognosis in NSCLC patients.
Zhang M; Wen F; Zhao K
J Clin Lab Anal; 2021 Aug; 35(8):e23625. PubMed ID: 34216509
[TBL] [Abstract][Full Text] [Related]
24. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer.
Yoh K; Ishii G; Yokose T; Minegishi Y; Tsuta K; Goto K; Nishiwaki Y; Kodama T; Suga M; Ochiai A
Clin Cancer Res; 2004 Mar; 10(5):1691-7. PubMed ID: 15014021
[TBL] [Abstract][Full Text] [Related]
26. Targeting LUNX inhibits non-small cell lung cancer growth and metastasis.
Zheng X; Cheng M; Fu B; Fan X; Wang Q; Yu X; Sun R; Tian Z; Wei H
Cancer Res; 2015 Mar; 75(6):1080-90. PubMed ID: 25600649
[TBL] [Abstract][Full Text] [Related]
27. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].
Chang C; Wang P; Yang H; Li L; Zhang LB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548
[TBL] [Abstract][Full Text] [Related]
28. [Expression and clinical significance of MAPK in non-small cell lung cancer].
Zhang ZF; Ma JQ; Zhang L
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):339-42. PubMed ID: 15854513
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis.
Min SH; Zheng QQ
Medicine (Baltimore); 2021 Nov; 100(47):e27919. PubMed ID: 34964763
[TBL] [Abstract][Full Text] [Related]
30. Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis.
Li J; Li ZN; Yu LC; Shi SB; Ge LP; Wu JR; Hu YM
Clin Transl Oncol; 2013 Nov; 15(11):882-8. PubMed ID: 23404657
[TBL] [Abstract][Full Text] [Related]
31. Expression of MRP1, BCRP, LRP and ERCC1 as prognostic factors in non-small cell lung cancer patients receiving postoperative cisplatin-based chemotherapy.
Li XQ; Li J; Shi SB; Chen P; Yu LC; Bao QL
Int J Biol Markers; 2009; 24(4):230-7. PubMed ID: 20082278
[TBL] [Abstract][Full Text] [Related]
32. [Expression of NUSAP1 and its relationship with prognosis in non-small cell lung cancer].
Yu Z; Li XM; Huai M; Cao SS; Han HY; Liu HT
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):522-526. PubMed ID: 31357839
[No Abstract] [Full Text] [Related]
33. The expression and clinical significance of miRNA-99a and miRNA-224 in non-small cell lung cancer.
Yan HZ; Wang W; Du X; Jiang XD; Lin CY; Guo JL; Zhang J
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1545-1552. PubMed ID: 30840277
[TBL] [Abstract][Full Text] [Related]
34. Expression and clinical significance of lung-specific X protein mRNA in bronchial brushing specimens from patients with or without lung cancer.
Lv M; Wu MZ; Zhao YJ; Yang DI; Wang EH; Wu GP
Respirology; 2011 Oct; 16(7):1076-80. PubMed ID: 21651644
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic utility of LUNX mRNA and VEGF mRNA in pleural fluid for differentiating benign from malignant origin.
Bao QL; Li J; Sun W; Jiang HG; Zhu LR; Wang Y
Jpn J Clin Oncol; 2014 Dec; 44(12):1198-205. PubMed ID: 25425729
[TBL] [Abstract][Full Text] [Related]
36. Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
Zheng S; Chang Y; Hodges KB; Sun Y; Ma X; Xue Y; Williamson SR; Lopez-Beltran A; Montironi R; Cheng L
Anticancer Res; 2010 Mar; 30(3):713-8. PubMed ID: 20392988
[TBL] [Abstract][Full Text] [Related]
37. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
38. [Inverse correlation of S100A4 and E-cad protein expression and their clinical significance in non-small cell lung cancer].
Qi RX; Xu XY
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):681-4. PubMed ID: 18246798
[TBL] [Abstract][Full Text] [Related]
39. Correlation of CT indicators of NSCLC and pathological features and the expression level of p53 and c-myc.
Li HS; Lv RQ; Liu L
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):135-141. PubMed ID: 29364480
[TBL] [Abstract][Full Text] [Related]
40. [Feasibility and its clinical significance of detection of LUNX mRNA expression in diagnosis of micrometastasis for non-small cell lung cancer].
Zhang P; Liu Y; Chen J; Song S; Shang Z
Zhongguo Fei Ai Za Zhi; 2006 Dec; 9(6):506-10. PubMed ID: 21182811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
